CSL's next gen a blood curdler

Research doesn't always go to plan, but 2013 was a good year for CSL.

Jason Prowd and I recently attended the CSL research and development day. At times, it felt like being in a molecular biology lecture but the presentations are a reminder why CSL’s management deserves respect. Though unmistakably scientists, they’re a rare breed – scientists with business acumen.

In a field full of nasty surprises, there were no major ones, neither good nor bad, for CSL’s research pipeline over the past year. Research and development (R&D), however, is inherently risky.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles